HUE055411T2 - Génmódosított ligáz variánsok - Google Patents

Génmódosított ligáz variánsok

Info

Publication number
HUE055411T2
HUE055411T2 HUE18798770A HUE18798770A HUE055411T2 HU E055411 T2 HUE055411 T2 HU E055411T2 HU E18798770 A HUE18798770 A HU E18798770A HU E18798770 A HUE18798770 A HU E18798770A HU E055411 T2 HUE055411 T2 HU E055411T2
Authority
HU
Hungary
Prior art keywords
engineered ligase
ligase variants
variants
engineered
ligase
Prior art date
Application number
HUE18798770A
Other languages
English (en)
Inventor
Mathew Miller
Jonathan Vroom
Nikki Dellas
Donald Baskerville
Sandy Gomes
David Elgart
Judy Viduya
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of HUE055411T2 publication Critical patent/HUE055411T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y605/00Ligases forming phosphoric ester bonds (6.5)
    • C12Y605/01Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
    • C12Y605/01001DNA ligase (ATP) (6.5.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00Reaction characterised by the enzymatic activity
    • C12Q2521/50Other enzymatic activities
    • C12Q2521/501Ligase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10Modifications characterised by
    • C12Q2525/191Modifications characterised by incorporating an adaptor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122Massive parallel sequencing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HUE18798770A 2017-05-08 2018-05-07 Génmódosított ligáz variánsok HUE055411T2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762503075P 2017-05-08 2017-05-08
US201762540734P 2017-08-03 2017-08-03
US201762587030P 2017-11-16 2017-11-16

Publications (1)

Publication Number Publication Date
HUE055411T2 true HUE055411T2 (hu) 2021-11-29

Family

ID=64014642

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18798770A HUE055411T2 (hu) 2017-05-08 2018-05-07 Génmódosított ligáz variánsok

Country Status (15)

Country Link
US (1) US20180320162A1 (hu)
EP (2) EP3957723A3 (hu)
JP (2) JP7401902B2 (hu)
KR (1) KR20200003903A (hu)
CN (1) CN110914415A (hu)
AU (1) AU2018266606A1 (hu)
BR (1) BR112019023337A2 (hu)
CA (1) CA3062550A1 (hu)
DK (1) DK3635101T3 (hu)
ES (1) ES2887078T3 (hu)
HU (1) HUE055411T2 (hu)
MX (1) MX2019013289A (hu)
PL (1) PL3635101T3 (hu)
SG (1) SG11201909957TA (hu)
WO (1) WO2018208665A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10837009B1 (en) 2017-12-22 2020-11-17 New England Biolabs, Inc. DNA ligase variants
SG11202107418SA (en) 2019-01-06 2021-08-30 10X Genomics Inc Methods and systems for enrichment of barcodes
SG11202110592QA (en) 2019-03-27 2021-10-28 10X Genomics Inc Systems and methods for processing rna from cells
CN113774032B (zh) * 2021-11-12 2022-03-01 翌圣生物科技(上海)股份有限公司 重组t4连接酶突变体、编码dna及ngs建库方法
US11685913B1 (en) * 2022-02-18 2023-06-27 Abclonal Science, Inc. T4 DNA ligase variants with increased resistance to salt
US11788082B2 (en) * 2022-02-22 2023-10-17 Abclonal Science, Inc. T4 DNA ligase variants with increased thermostability
US20230295707A1 (en) * 2022-03-21 2023-09-21 Abclonal Science, Inc. T4 DNA Ligase Variants with Increased Ligation Efficiency
WO2024123733A1 (en) * 2022-12-05 2024-06-13 Twist Bioscience Corporation Enzymes for library preparation
CN115896047B (zh) * 2022-12-12 2023-06-16 南京诺唯赞生物科技股份有限公司 重组t4 dna连接酶突变体、融合蛋白及其应用
WO2024138664A1 (zh) * 2022-12-30 2024-07-04 深圳华大生命科学研究院 一种核酸连接酶及其应用
CN116218953A (zh) * 2023-01-03 2023-06-06 南京诺唯赞生物科技股份有限公司 一种连接核酸片段与接头的方法
CN117946985B (zh) * 2024-03-27 2024-05-28 翌圣生物科技(上海)股份有限公司 突变型t4 dna连接酶、试剂盒及其在文库构建中的应用

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
DE69523052T2 (de) 1994-06-03 2002-06-20 Novo Nordisk Biotech, Inc. Gereinigte myceliophthora laccasen und nukleinsäuren dafür kodierend
CN1151762A (zh) 1994-06-30 1997-06-11 诺沃诺尔迪斯克生物技术有限公司 非毒性、非产毒性、非致病性镰孢属表达系统及所用启动子和终止子
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
AU6029998A (en) 1997-01-17 1998-08-07 Regents Of The University Of Minnesota Dna molecules and protein displaying improved triazine compound degrading ability
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
WO1998031837A1 (en) 1997-01-17 1998-07-23 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
CA2313380C (en) 1997-12-08 2008-12-30 California Institute Of Technology Method for creating polynucleotide and polypeptide sequences
IL138800A0 (en) 1998-04-02 2001-10-31 Tellus Genetic Resources Inc A method of identifying a plant with a lesion in a gene sequence
JP2002513550A (ja) 1998-05-01 2002-05-14 マキシジェン, インコーポレイテッド Dnaシャッフリングを使用する病害虫抵抗性遺伝子の至適化
CA2335269A1 (en) 1998-06-17 1999-12-23 Maxygen, Inc. Method for producing polynucleotides with desired properties
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
EP1104459A1 (en) 1998-08-12 2001-06-06 Maxygen, Inc. Dna shuffling of monooxygenase genes for production of industrial chemicals
EP1119616A2 (en) 1998-10-07 2001-08-01 Maxygen, Inc. Dna shuffling to produce nucleic acids for mycotoxin detoxification
AU1619400A (en) 1998-11-10 2000-05-29 Maxygen, Inc. Modified adp-glucose pyrophosphorylase for improvement and optimization of plantphenotypes
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
DE60044223D1 (de) 1999-01-19 2010-06-02 Maxygen Inc Durch oligonukleotide-vermittelte nukleinsäuren-rekombination
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
US8457903B1 (en) 1999-01-19 2013-06-04 Codexis Mayflower Holdings, Llc Method and/or apparatus for determining codons
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US20070065838A1 (en) 1999-01-19 2007-03-22 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US7873477B1 (en) 2001-08-21 2011-01-18 Codexis Mayflower Holdings, Llc Method and system using systematically varied data libraries
KR20010102069A (ko) 1999-02-11 2001-11-15 추후제출 고효율 질량 분석
AU3391900A (en) 1999-03-05 2000-09-21 Maxygen, Inc. Encryption of traits using split gene sequences
US6703240B1 (en) 1999-04-13 2004-03-09 Maxygar, Inc. Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
US6686515B1 (en) 1999-11-23 2004-02-03 Maxygen, Inc. Homologous recombination in plants
IL150291A0 (en) 2000-01-11 2002-12-01 Maxygen Inc Integrated systems and methods for diversity generation and screening
WO2001075767A2 (en) 2000-03-30 2001-10-11 Maxygen, Inc. In silico cross-over site selection
EP1287123B1 (en) 2000-04-03 2011-03-02 Maxygen, Inc. Subtilisin variant
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
DK2315145T3 (en) 2002-03-01 2016-01-25 Codexis Mayflower Holdings Llc Methods, systems, and software for identifying the functional biomolecules
AU2003213846A1 (en) 2002-03-09 2003-09-29 Maxygen, Inc. Optimization of crossover points for directed evolution
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
EP2250595B1 (en) 2008-02-12 2017-06-14 Codexis, Inc. Method of selecting an optimized diverse population of variants
WO2009102901A1 (en) 2008-02-12 2009-08-20 Codexis, Inc. Method of generating an optimized, diverse population of variants
ES2705694T3 (es) 2008-06-13 2019-03-26 Codexis Inc Método de síntesis de variantes de polinucleótidos
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
CN102597006A (zh) * 2009-09-16 2012-07-18 梅西大学 融合多肽以及其应用
WO2013022504A1 (en) 2011-05-06 2013-02-14 New England Biolabs, Inc. Ligation enhancement
HUE042817T2 (hu) 2011-06-28 2019-07-29 Codexis Inc Fehérjevariánsok elõállítása régiókeveréssel
US20150010525A1 (en) * 2012-01-23 2015-01-08 The Regents Of The University Of California Catalytic Tagging System to Study Macro-Molecular Interactions Using Engineered Ubiquitin Ligase and Ubiquitin-Like Proteins to Facilitate Substrate Identification
US20150133698A1 (en) 2012-04-20 2015-05-14 Codexis, Inc. Production of fatty alcohols from engineered microorganisms
SG11201507264YA (en) * 2013-03-15 2015-10-29 Theranos Inc Thermostable blunt-end ligase and methods of use
BR112016006285B1 (pt) * 2013-09-27 2022-09-06 Codexis, Inc Método implementado usando um sistema de computador, meio de armazenamento legível por computador, e, sistema
GB201612011D0 (en) * 2016-07-11 2016-08-24 Glaxosmithkline Ip Dev Ltd Novel processes for the production of oligonucleotides
US10837009B1 (en) * 2017-12-22 2020-11-17 New England Biolabs, Inc. DNA ligase variants

Also Published As

Publication number Publication date
MX2019013289A (es) 2020-01-15
EP3635101A4 (en) 2020-09-30
SG11201909957TA (en) 2019-11-28
EP3635101B1 (en) 2021-08-18
EP3957723A2 (en) 2022-02-23
DK3635101T3 (da) 2021-09-20
CN110914415A (zh) 2020-03-24
JP2020518278A (ja) 2020-06-25
US20180320162A1 (en) 2018-11-08
EP3635101A1 (en) 2020-04-15
EP3957723A3 (en) 2022-04-20
JP2023166579A (ja) 2023-11-21
ES2887078T3 (es) 2021-12-21
KR20200003903A (ko) 2020-01-10
AU2018266606A1 (en) 2019-11-14
CA3062550A1 (en) 2018-11-15
WO2018208665A1 (en) 2018-11-15
BR112019023337A2 (pt) 2020-06-16
JP7401902B2 (ja) 2023-12-20
PL3635101T3 (pl) 2021-12-13

Similar Documents

Publication Publication Date Title
HK1257480A1 (zh) 工程病毒
PL3635101T3 (pl) Poddane inżynierii warianty ligazy
HK1257676A1 (zh) 工程化 crispr-cas 9 核酸酶
GB201809886D0 (en) No title
IL251822A0 (en) Variants of interferon alpha-2B
GB201801962D0 (en) No title
GB201717717D0 (en) No title
GB201714803D0 (en) No Title
ZA202001147B (en) Construction component
HRP20190089T1 (hr) Vortioksetin piroglutamat
GB201802230D0 (en) No title
GB201819470D0 (en) No title
GB201721012D0 (en) No title
HK1251001A1 (zh) Il-37變體
GB201903157D0 (en) No title
GB201805111D0 (en) No title
GB201810211D0 (en) Foregin title
GB201720631D0 (en) No title
GB201705572D0 (en) No title
GB201721710D0 (en) No title
GB201818557D0 (en) No title
GB201720509D0 (en) No title
GB201811831D0 (en) No title
GB201817796D0 (en) No title
GB201817927D0 (en) No title